Szela Mary T's Form 4 filing
TriSalus Life Sciences, Inc. (TLSI) · filed Sep 13, 2024
- Accession no.
- 0001415889-24-023390
- Filed
- Sep 13, 2024
- Trade date
- Sep 12-13, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $75.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Szela Mary TCIK 0001410289 | Director, Officer (CEO AND PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2024 | Common Stock | PPurchaseAcquired | +7,520 | $5.20 | +$39,104 | 377,382 | Direct | |
| Sep 13, 2024 | Common Stock | PPurchaseAcquired | +1,295 | $4.83 | +$6,254.85 | 378,677 | Direct | |
| Sep 13, 2024 | Common Stock | PPurchaseAcquired | +6,000 | $5.00 | +$30,000 | 384,677 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.